Sino Biopharmaceutical Limited (OTCMKTS:SBMFF – Get Free Report) reached a new 52-week low during trading on Friday . The stock traded as low as $0.31 and last traded at $0.31, with a volume of 0 shares. The stock had previously closed at $0.31.
Sino Biopharmaceutical Stock Performance
The firm has a 50 day moving average of $0.36 and a 200 day moving average of $0.39.
About Sino Biopharmaceutical
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection.
Recommended Stories
- Five stocks we like better than Sino Biopharmaceutical
- Investing in Construction Stocks
- MarketBeat Week in Review – 4/22 – 4/26
- What Makes a Stock a Good Dividend Stock?
- 3 Stocks Leading the U.S. Agriculture Comeback
- Which Wall Street Analysts are the Most Accurate?
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.